Cleared Traditional

K920318 - CEDIA FERRITIN ASSAY

K920318 is an FDA 510(k) clearance for CEDIA FERRITIN ASSAY, manufactured by Microgenics Corp.. The device is a Class 2 Chemistry device with product code JMG cleared through the Traditional 510(k) pathway after a 132-day FDA review.

K920318 · Microgenics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
132d
Days
Class 2
Risk

K920318 is an FDA 510(k) clearance for the CEDIA FERRITIN ASSAY. Classified as Radioimmunoassay (two-site Solid Phase), Ferritin (product code JMG), Class II - Special Controls.

Submitted by Microgenics Corp. (Concord, US). The FDA issued a Cleared decision on June 4, 1992 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5340 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Microgenics Corp. devices

FDA 510(k) Submission Details - K920318

510(k) Number K920318 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 24, 1992
Decision Date June 04, 1992
Days to Decision 132 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d slower than avg
Panel avg: 88d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JMG Device Classification - Class 2, Special Controls

Product Code JMG Radioimmunoassay (two-site Solid Phase), Ferritin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JMG Radioimmunoassay (two-site Solid Phase), Ferritin

All 20
Devices cleared under the same product code (JMG) and FDA review panel - the closest regulatory comparables to K920318.
IMMULITE FERRITIN
K925848 · Diagnostic Products Corp. · Jan 1993
ACCESS FERRITIN ASSAY
K926221 · Bio-Rad Laboratories, Inc. · Jan 1993
COBAS CORE FERRITIN EIA
K920829 · Roche Diagnostic Systems, Inc. · Jun 1992
MILENIA (TM) FERRITIN
K902997 · Diagnostic Products Corp. · Aug 1990
CLINICAL ASSAYS GAMMACOAT [125I] FERRITIN IMMUNO.
K881138 · Baxter Healthcare Corp · Apr 1988
MEDIX BIOTECH FERRITIN ENZYME IMMUNOASSAY TEST KIT
K873730 · Medix Biotech, Inc. · Nov 1987